On the recordNovember 13, 2023
Will the publication of phase three clinical trial results with that last month all signs point toward MDMA assisted therapy receiving FDA approval within the next year.
Source
congress.govJack Bergman: “Will the publication of phase three clinical trial results with that last month all signs point toward MDMA assisted…”
Editor's note · Context
Bergman expresses optimism about MDMA therapy's potential FDA approval.
Share
More from Jack Bergman
Jun 4, 2024
May I inquire as to how much time is remaining. The Acting CHAIR. The gentleman from Michigan has 2 minutes remaining.
Feb 25, 2025
I thank the chairman for yielding the time. Mr. Speaker, it is crucial we are clear about the focus of today's debate. Our aim is not to remove vulnerable Americans from the government assistance programs they and their families depends…
Dec 4, 2023
While we are considering this bill today, I would remind my colleagues that this legislation is also a part of a comprehensive veterans package being negotiated between the House and Senate Veterans' Affairs Committees. Mr. Speaker, I look…
Jun 4, 2024
Psychedelic-assisted therapies have the potential to be the first genuine advancement in the treatment of veterans' mental health in decades. It is essential that the VA continue their efforts to research these compounds and do everything…
Other voices in this conversation
